XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-In Capital
Common Stock Held in Treasury
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2020     88,554,962          
Beginning balance at Dec. 31, 2020 $ 583,184   $ 1 $ 770,714 $ (897) $ (187,691)   $ 1,057
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common stock issued for exercise of employee-based stock options (in shares)     271,946          
Common stock issued for exercise of employee-based stock options 2,427     2,427        
Stock-based compensation 911     911        
Net income 628         628    
Unrealized loss on hedged transactions, net of tax (134)             (134)
Foreign currency translation adjustment, net of tax 372             372
Ending Balance (in shares) at Mar. 31, 2021     88,826,908          
Ending Balance at Mar. 31, 2021 587,388   $ 1 774,052 (897) (187,063)   1,295
Beginning balance (in shares) at Dec. 31, 2020     88,554,962          
Beginning balance at Dec. 31, 2020 583,184   $ 1 770,714 (897) (187,691)   1,057
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 4,025              
Unrealized loss on hedged transactions, net of tax (322)              
Foreign currency translation adjustment, net of tax 594              
Ending Balance (in shares) at Jun. 30, 2021     88,826,908          
Ending Balance at Jun. 30, 2021 591,584   $ 1 774,817 (897) (183,666)   1,329
Beginning balance (in shares) at Mar. 31, 2021     88,826,908          
Beginning balance at Mar. 31, 2021 587,388   $ 1 774,052 (897) (187,063)   1,295
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation 765     765        
Net income 3,397         3,397    
Unrealized loss on hedged transactions, net of tax (188)             (188)
Foreign currency translation adjustment, net of tax 222             222
Ending Balance (in shares) at Jun. 30, 2021     88,826,908          
Ending Balance at Jun. 30, 2021 591,584   $ 1 774,817 (897) (183,666)   1,329
Beginning balance (in shares) at Dec. 31, 2021     95,746,975          
Beginning balance at Dec. 31, 2021 709,624 $ (198) $ 68 916,578 (897) (206,218) $ (198) 93
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)     1,112          
Common stock issued for exercise of employee-based stock options (in shares)     8,486          
Common stock issued for exercise of employee-based stock options 80     80        
Issuance of restricted shares, net of forfeitures and vesting (in shares)     533,095          
Issuance of restricted shares, net of forfeitures and vestings     $ 5 (5)        
Stock-based compensation 5,108     5,108        
Net income 6,236         6,236    
Foreign currency translation adjustment, net of tax       (8)       283
Foreign currency translation adjustment, net of tax 275              
Ending Balance (in shares) at Mar. 31, 2022     96,289,668          
Ending Balance at Mar. 31, 2022 $ 721,125   $ 73 921,753 (897) (200,180)   376
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2016-13              
Beginning balance (in shares) at Dec. 31, 2021     95,746,975          
Beginning balance at Dec. 31, 2021 $ 709,624 $ (198) $ 68 916,578 (897) (206,218) $ (198) 93
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 17,807              
Unrealized loss on hedged transactions, net of tax 0              
Foreign currency translation adjustment, net of tax (3,200)              
Ending Balance (in shares) at Jun. 30, 2022     96,410,267          
Ending Balance at Jun. 30, 2022 735,946   $ 73 928,486 (897) (188,609)   (3,107)
Beginning balance (in shares) at Mar. 31, 2022     96,289,668          
Beginning balance at Mar. 31, 2022 721,125   $ 73 921,753 (897) (200,180)   376
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)     1,812          
Common stock issued for exercise of employee-based stock options (in shares)     76,399          
Common stock issued for exercise of employee-based stock options 734     734        
Issuance of restricted shares, net of forfeitures and vesting (in shares)     42,388          
Stock-based compensation 6,023     6,023        
Net income 11,571         11,571    
Unrealized loss on hedged transactions, net of tax 0              
Foreign currency translation adjustment, net of tax (3,483)     (24)       (3,483)
Foreign currency translation adjustment, net of tax (3,507)              
Ending Balance (in shares) at Jun. 30, 2022     96,410,267          
Ending Balance at Jun. 30, 2022 $ 735,946   $ 73 $ 928,486 $ (897) $ (188,609)   $ (3,107)